In a 6 p.m. news release on Tuesday, Biogen (ticker: BIIB) said CFO Jeffrey Capello, who has been in the role since December 2017, would step down on Aug. 15.The company reported non-GAAP diluted earnings per share for the quarter of $10.26, beating the S&P Capital IQ Consensus estimate of $8.01.